Anti-Osteoclast Effect of Exportin-1 Inhibitor Eltanexor on Osteoporosis Depends on Nuclear Accumulation of IκBα–NF-κB p65 Complex
Osteoporosis affects around 200 million people globally, with menopausal women accounting for the bulk of cases. In the occurrence and development of osteoporosis, a key role is played by osteoclasts. Excessive osteoclast-mediated bone resorption activity reduces bone mass and increases bone fragili...
Main Authors: | Junchun Chen, Dezhi Song, Yang Xu, Liwei Wu, Lili Tang, YuanGang Su, Xiaoxiao Xie, Jinmin Zhao, Jiake Xu, Qian Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.896108/full |
Similar Items
-
Nuclear Export Inhibitor KPT-8602 Synergizes with PARP Inhibitors in Escalating Apoptosis in Castration Resistant Cancer Cells
by: Md. Hafiz Uddin, et al.
Published: (2021-06-01) -
The XPO1 Inhibitor KPT-8602 Ameliorates Parkinson’s Disease by Inhibiting the NF-κB/NLRP3 Pathway
by: Shuhan Liu, et al.
Published: (2022-06-01) -
Next-Generation SINE Compound KPT−8602 Ameliorates Dystrophic Pathology in Zebrafish and Mouse Models of DMD
by: Katherine G. English, et al.
Published: (2022-09-01) -
Eltanexor Effectively Reduces Viability of Glioblastoma and Glioblastoma Stem-Like Cells at Nano-Molar Concentrations and Sensitizes to Radiotherapy and Temozolomide
by: Katharina Otte, et al.
Published: (2022-08-01) -
Identification of nuclear export inhibitor-based combination therapies in preclinical models of triple-negative breast cancer
by: Narmeen S. Rashid, et al.
Published: (2021-12-01)